Evommune, Inc. (EVMN)
9.45
-0.20
(-2.07%)
USD |
NYSE |
Sep 21, 16:00
9.45
0.00 (0.00%)
After-Hours: 20:00
Evommune Market Cap : 342.86M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 350.12M |
| September 17, 2026 | 339.96M |
| September 16, 2026 | 339.96M |
| September 15, 2026 | 362.46M |
| September 14, 2026 | 378.42M |
| September 11, 2026 | 382.41M |
| September 10, 2026 | 383.14M |
| September 09, 2026 | 393.29M |
| September 08, 2026 | 474.57M |
| September 04, 2026 | 445.18M |
| September 03, 2026 | 435.38M |
| September 02, 2026 | 452.80M |
| September 01, 2026 | 452.80M |
| August 31, 2026 | 459.33M |
| August 28, 2026 | 480.01M |
| August 27, 2026 | 489.08M |
| August 26, 2026 | 511.94M |
| August 25, 2026 | 500.33M |
| August 24, 2026 | 495.97M |
| August 21, 2026 | 508.67M |
| August 20, 2026 | 492.34M |
| August 19, 2026 | 544.59M |
| August 18, 2026 | 515.93M |
| August 17, 2026 | 517.02M |
| August 14, 2026 | 531.53M |
| Date | Value |
|---|---|
| August 13, 2026 | 510.48M |
| August 12, 2026 | 512.30M |
| August 11, 2026 | 515.56M |
| August 10, 2026 | 510.48M |
| August 07, 2026 | 510.85M |
| August 06, 2026 | 485.45M |
| August 05, 2026 | 472.39M |
| August 04, 2026 | 475.65M |
| August 03, 2026 | 417.45M |
| July 31, 2026 | 405.21M |
| July 30, 2026 | 408.81M |
| July 29, 2026 | 398.00M |
| July 28, 2026 | 405.21M |
| July 27, 2026 | 413.13M |
| July 24, 2026 | 409.17M |
| July 23, 2026 | 407.73M |
| July 22, 2026 | 410.61M |
| July 21, 2026 | 440.14M |
| July 20, 2026 | 415.29M |
| July 17, 2026 | 437.26M |
| July 16, 2026 | 421.78M |
| July 15, 2026 | 448.43M |
| July 14, 2026 | 431.86M |
| July 13, 2026 | 435.82M |
| July 10, 2026 | 475.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| PS Ratio | 31.39 |
| PEG Ratio | -0.1641 |
| Price to Book Value | 1.235 |
| Price | 9.45 |
| Earnings Yield | -29.93% |
| PEGY Ratio | -0.1641 |